JPWO2023015309A5 - - Google Patents

Info

Publication number
JPWO2023015309A5
JPWO2023015309A5 JP2024507108A JP2024507108A JPWO2023015309A5 JP WO2023015309 A5 JPWO2023015309 A5 JP WO2023015309A5 JP 2024507108 A JP2024507108 A JP 2024507108A JP 2024507108 A JP2024507108 A JP 2024507108A JP WO2023015309 A5 JPWO2023015309 A5 JP WO2023015309A5
Authority
JP
Japan
Prior art keywords
seq
amino acid
prime editor
acid sequence
prime
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024507108A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024530487A (ja
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/074628 external-priority patent/WO2023015309A2/en
Publication of JP2024530487A publication Critical patent/JP2024530487A/ja
Publication of JPWO2023015309A5 publication Critical patent/JPWO2023015309A5/ja
Pending legal-status Critical Current

Links

JP2024507108A 2021-08-06 2022-08-05 改善されたプライムエディターおよび使用方法 Pending JP2024530487A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163230688P 2021-08-06 2021-08-06
US63/230,688 2021-08-06
US202263388888P 2022-07-13 2022-07-13
US63/388,888 2022-07-13
PCT/US2022/074628 WO2023015309A2 (en) 2021-08-06 2022-08-05 Improved prime editors and methods of use

Publications (2)

Publication Number Publication Date
JP2024530487A JP2024530487A (ja) 2024-08-21
JPWO2023015309A5 true JPWO2023015309A5 (enrdf_load_stackoverflow) 2025-08-20

Family

ID=83188605

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024507108A Pending JP2024530487A (ja) 2021-08-06 2022-08-05 改善されたプライムエディターおよび使用方法

Country Status (6)

Country Link
US (1) US20250270593A1 (enrdf_load_stackoverflow)
EP (1) EP4381057A2 (enrdf_load_stackoverflow)
JP (1) JP2024530487A (enrdf_load_stackoverflow)
AU (1) AU2022325166A1 (enrdf_load_stackoverflow)
CA (1) CA3227004A1 (enrdf_load_stackoverflow)
WO (1) WO2023015309A2 (enrdf_load_stackoverflow)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10077453B2 (en) 2014-07-30 2018-09-18 President And Fellows Of Harvard College CAS9 proteins including ligand-dependent inteins
WO2018165631A1 (en) 2017-03-09 2018-09-13 President And Fellows Of Harvard College Cancer vaccine
JP2020534795A (ja) 2017-07-28 2020-12-03 プレジデント アンド フェローズ オブ ハーバード カレッジ ファージによって支援される連続的進化(pace)を用いて塩基編集因子を進化させるための方法および組成物
WO2019118949A1 (en) 2017-12-15 2019-06-20 The Broad Institute, Inc. Systems and methods for predicting repair outcomes in genetic engineering
US12351837B2 (en) 2019-01-23 2025-07-08 The Broad Institute, Inc. Supernegatively charged proteins and uses thereof
CA3231677A1 (en) 2021-09-08 2023-03-16 Flagship Pioneering Innovations Vi, Llc Methods and compositions for modulating a genome
WO2024077267A1 (en) 2022-10-07 2024-04-11 The Broad Institute, Inc. Prime editing methods and compositions for treating triplet repeat disorders
CN118995664A (zh) * 2023-05-22 2024-11-22 江西农业大学 基于perv逆转录酶的先导编辑系统
WO2024243415A1 (en) 2023-05-23 2024-11-28 The Broad Institute, Inc. Evolved and engineered prime editors with improved editing efficiency
US20250027087A1 (en) 2023-07-21 2025-01-23 Crispr Therapeutics Ag Modulating expression of alas1 (5'-aminolevulinate synthase 1) gene
WO2025048436A1 (ko) * 2023-08-29 2025-03-06 성균관대학교산학협력단 Eys 유전자 교정 프라임 에디터 및 그 용도
WO2025096936A2 (en) 2023-11-03 2025-05-08 The Broad Institute, Inc. Use of prime editing in correcting mutations in cdkl5
WO2025151814A1 (en) 2024-01-10 2025-07-17 The Broad Institute, Inc. Use of prime editing in correcting mutations in cftr

Family Cites Families (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4217344A (en) 1976-06-23 1980-08-12 L'oreal Compositions containing aqueous dispersions of lipid spheres
US4235871A (en) 1978-02-24 1980-11-25 Papahadjopoulos Demetrios P Method of encapsulating biologically active materials in lipid vesicles
US4186183A (en) 1978-03-29 1980-01-29 The United States Of America As Represented By The Secretary Of The Army Liposome carriers in chemotherapy of leishmaniasis
US4261975A (en) 1979-09-19 1981-04-14 Merck & Co., Inc. Viral liposome particle
US4485054A (en) 1982-10-04 1984-11-27 Lipoderm Pharmaceuticals Limited Method of encapsulating biologically active materials in multilamellar lipid vesicles (MLV)
US4501728A (en) 1983-01-06 1985-02-26 Technology Unlimited, Inc. Masking of liposomes from RES recognition
US5049386A (en) 1985-01-07 1991-09-17 Syntex (U.S.A.) Inc. N-ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)Alk-1-YL-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US4946787A (en) 1985-01-07 1990-08-07 Syntex (U.S.A.) Inc. N-(ω,(ω-1)-dialkyloxy)- and N-(ω,(ω-1)-dialkenyloxy)-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US4897355A (en) 1985-01-07 1990-01-30 Syntex (U.S.A.) Inc. N[ω,(ω-1)-dialkyloxy]- and N-[ω,(ω-1)-dialkenyloxy]-alk-1-yl-N,N,N-tetrasubstituted ammonium lipids and uses therefor
US4774085A (en) 1985-07-09 1988-09-27 501 Board of Regents, Univ. of Texas Pharmaceutical administration systems containing a mixture of immunomodulators
US4837028A (en) 1986-12-24 1989-06-06 Liposome Technology, Inc. Liposomes with enhanced circulation time
US5244797B1 (en) 1988-01-13 1998-08-25 Life Technologies Inc Cloned genes encoding reverse transcriptase lacking rnase h activity
US5264618A (en) 1990-04-19 1993-11-23 Vical, Inc. Cationic lipids for intracellular delivery of biologically active molecules
WO1991017424A1 (en) 1990-05-03 1991-11-14 Vical, Inc. Intracellular delivery of biologically active substances by means of self-assembling lipid complexes
US6534261B1 (en) 1999-01-12 2003-03-18 Sangamo Biosciences, Inc. Regulation of endogenous gene expression in cells using zinc finger proteins
WO2001038547A2 (en) 1999-11-24 2001-05-31 Mcs Micro Carrier Systems Gmbh Polypeptides comprising multimers of nuclear localization signals or of protein transduction domains and their use for transferring molecules into cells
US8178291B2 (en) 2005-02-18 2012-05-15 Monogram Biosciences, Inc. Methods and compositions for determining hypersusceptibility of HIV-1 to non-nucleoside reverse transcriptase inhibitors
US9783791B2 (en) 2005-08-10 2017-10-10 Agilent Technologies, Inc. Mutant reverse transcriptase and methods of use
CN101668848B (zh) 2007-04-26 2014-10-22 雷蒙特亚特特拉维夫大学有限公司 来自口腔粘膜的多能自体干细胞和使用方法
EP2342336B1 (en) 2008-09-05 2016-12-14 President and Fellows of Harvard College Continuous directed evolution of proteins and nucleic acids
CN102421791A (zh) 2009-03-04 2012-04-18 得克萨斯系统大学评议会 稳定化逆转录酶融合蛋白
US8889394B2 (en) 2009-09-07 2014-11-18 Empire Technology Development Llc Multiple domain proteins
US9458484B2 (en) 2010-10-22 2016-10-04 Bio-Rad Laboratories, Inc. Reverse transcriptase mixtures with improved storage stability
EP2655614B1 (en) 2010-12-22 2017-03-15 President and Fellows of Harvard College Continuous directed evolution
CA2850411C (en) 2011-09-28 2023-08-15 Era Biotech, S.A. Split inteins and uses thereof
JP2015522020A (ja) 2012-06-27 2015-08-03 ザ・トラスティーズ・オブ・プリンストン・ユニバーシティThe Trustees Of Princeton University スプリットインテイン、複合体およびそれらの使用
EP2904101B1 (en) 2012-10-03 2019-06-12 Agrivida, Inc. Intein-modified proteases, their production and industrial applications
JO3470B1 (ar) 2012-10-08 2020-07-05 Merck Sharp & Dohme مشتقات 5- فينوكسي-3h-بيريميدين-4-أون واستخدامها كمثبطات ناسخ عكسي ل hiv
US9737604B2 (en) 2013-09-06 2017-08-22 President And Fellows Of Harvard College Use of cationic lipids to deliver CAS9
WO2015134121A2 (en) 2014-01-20 2015-09-11 President And Fellows Of Harvard College Negative selection and stringency modulation in continuous evolution systems
CA2963148C (en) 2014-10-28 2024-04-30 Agrivida, Inc. Methods and compositions for stabilizing trans-splicing intein modified proteases
WO2016168631A1 (en) 2015-04-17 2016-10-20 President And Fellows Of Harvard College Vector-based mutagenesis system
US9580698B1 (en) 2016-09-23 2017-02-28 New England Biolabs, Inc. Mutant reverse transcriptase
US20200140835A1 (en) * 2017-06-06 2020-05-07 The General Hospital Corporation Engineered CRISPR-Cas9 Nucleases
WO2019092042A1 (en) * 2017-11-10 2019-05-16 Novozymes A/S Temperature-sensitive cas9 protein
SG11202109679VA (en) * 2019-03-19 2021-10-28 Broad Inst Inc Methods and compositions for editing nucleotide sequences
WO2021080922A1 (en) * 2019-10-21 2021-04-29 The Trustees Of Columbia University In The City Of New York Methods of performing rna templated genome editing
CA3174486A1 (en) * 2020-03-04 2021-09-10 Flagship Pioneering Innovations Vi, Llc Methods and compositions for modulating a genome

Similar Documents

Publication Publication Date Title
Edwards et al. Automated DNA sequencing of the human HPRT locus
JPWO2023015309A5 (enrdf_load_stackoverflow)
CN109072235B (zh) 通过核递送crispr/cas9追踪并操纵细胞rna
JP2024038327A5 (enrdf_load_stackoverflow)
US5789206A (en) Method for ligating adaptors to nucleic acids which methods are useful for obtaining the ends of genes
JP2022062143A (ja) 腎臓病の処置のための組成物と方法
JPS62501470A (ja) 腫瘍壊死因子の精製、製造および使用法
CN108350454A (zh) 等位基因选择性基因编辑及其用途
JP2002519038A (ja) 多様性の高いライブラリーを製造する方法
JPS60252496A (ja) 新規なヒト生理活性ポリペプチド
JP2017510542A5 (enrdf_load_stackoverflow)
US5405775A (en) Retrons coding for hybrid DNA/RNA molecules
JP7684298B2 (ja) Rna分子を合成する方法
AU2022398241A1 (en) Modified prime editing guide rnas
WO2023086842A1 (en) Genome editing compositions and methods for treatment of fuchs endothelial corneal dystrophy
JPS6070086A (ja) コロナウイルス用ワクチンの調製方法
AU2022220203A1 (en) Curing disease by transcription regulatory gene editing
CN118922536A (zh) 分段核酸
JPWO2023004409A5 (enrdf_load_stackoverflow)
JP3680392B2 (ja) マイクロ遺伝子のランダム重合体作成方法
JPWO2022256440A5 (enrdf_load_stackoverflow)
JPWO2020146521A5 (enrdf_load_stackoverflow)
JPS62226928A (ja) 臓器機能改善剤
JP4395331B2 (ja) 核酸検出方法
CN118460655B (zh) 抑制FXI基因表达的siRNA的制备方法